HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in ...

Following review of the positive interim clinical study results from the Phase 1b/2a trial of BB-301, the U.S. Food and Drug Administration (FDA) granted Fast Track Designation (FTD) to BB-301 for the ...

Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir ...

The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating ...

The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year ...

Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve ...